Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NARI | US
-0.90
-2.10%
Healthcare
Medical Devices
30/06/2024
04/10/2024
41.92
41.76
42.43
41.51
Inari Medical Inc. builds minimally invasive novel and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever which is designed to core capture and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists interventional cardiologists and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical Inc. in September 2013. Inari Medical Inc. was incorporated in 2011 and is headquartered in Irvine California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
36.9%1 month
46.6%3 months
47.3%6 months
44.5%-
196.08
5.66
0.08
0.05
1.58K
4.25
-
-14.88M
2.44B
2.44B
-
-10.75
-83.90
22.50
-13.28
5.37
9.69
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
4.52
Range1M
7.27
Range3M
20.14
Rel. volume
0.77
Price X volume
28.44M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
AZTA | AZTA | Medical Instruments & Supplies | 48.27 | 2.36B | 1.15% | n/a | 3.59% |
LeMaitre Vascular Inc | LMAT | Medical Instruments & Supplies | 91.62 | 2.06B | 0.67% | 54.92 | 5.76% |
CONMED Corporation | CNMD | Medical Devices | 66.59 | 2.05B | -1.25% | 23.81 | 109.53% |
iRhythm Technologies Inc | IRTC | Medical Instruments & Supplies | 62.71 | 1.96B | -11.71% | n/a | 742.57% |
RxSight Inc. Common Stock | RXST | Medical Devices | 48.9 | 1.94B | 2.82% | n/a | 4.15% |
Warby Parker Inc. | WRBY | Medical Instruments & Supplies | 16.1 | 1.93B | 7.05% | n/a | 58.36% |
STAAR Surgical Company | STAA | Medical Instruments & Supplies | 35.07 | 1.73B | -1.71% | 112.82 | 8.87% |
AdaptHealth Corp | AHCO | Medical Devices | 10.44 | 1.40B | -3.51% | n/a | 150.02% |
AtriCure Inc | ATRC | Medical Instruments & Supplies | 27.63 | 1.35B | -0.25% | n/a | 16.30% |
Integra LifeSciences Holdings Corporation | IART | Medical Devices | 17 | 1.32B | -1.85% | 61.62 | 130.98% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
VeriFone Systems Inc | PAY | Building Products & Equipment | 20.8 | 2.59B | 4.58% | 76.96 | 2.10% |
HNI Corporation | HNI | Building Products & Equipment | 53.27 | 2.51B | 0.72% | 21.28 | 76.47% |
Kennedy-Wilson Holdings Inc | KW | Real Estate Services | 10.87 | 1.49B | -1.09% | n/a | 304.03% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
Marcus & Millichap Inc | MMI | Real Estate Services | 36.79 | 1.44B | -5.16% | n/a | 14.11% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
OpenTable Inc | OPEN | Real Estate Services | 1.99 | 1.40B | 4.74% | n/a | 290.30% |
Redfin Corporation | RDFN | Real Estate Services | 11.11 | 1.35B | -5.12% | n/a | -8279.77% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1,575.18 | 45.99 | Expensive |
Ent. to Revenue | 4.25 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 5.66 | 6.06 | Par |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 47.34 | 66.08 | Lower Risk |
Debt to Equity | 0.08 | 0.83 | Cheaper |
Debt to Assets | 0.05 | 0.28 | Cheaper |
Market Cap | 2.44B | 9.42B | Emerging |